LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 10.95 | 17.25 | 10 | 471 | 0.0212 | -0.1080 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 10.95 | 17.25 | 849 | 471 | 1.8004 | 1.2622 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.91 | 17.25 | 7 | 494 | 0.0141 | -0.1700 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.91 | 17.25 | 959 | 494 | 1.9379 | 1.2928 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.91 | 17.25 | 18 | 494 | 0.0364 | 0.0088 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.91 | 17.25 | 946 | 494 | 1.9117 | 1.2864 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 14.88 | 17.25 | 6 | 534 | 0.0112 | -0.1920 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 14.88 | 17.25 | 1039 | 534 | 1.9441 | 1.2873 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 14.88 | 17.25 | 17 | 534 | 0.0318 | -0.0030 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 14.88 | 17.25 | 1067 | 534 | 1.9965 | 1.2996 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 16.85 | 17.25 | 6 | 655 | 0.0092 | -0.1823 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 16.85 | 17.25 | 1173 | 655 | 1.7893 | 1.2345 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 16.85 | 17.25 | 18 | 655 | 0.0275 | 0.0081 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 16.85 | 17.25 | 1168 | 655 | 1.7817 | 1.2327 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 18.82 | 17.25 | 12 | 800 | 0.0150 | -0.0635 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 18.82 | 17.25 | 1328 | 800 | 1.6590 | 1.1915 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 18.82 | 17.25 | 23 | 800 | 0.0287 | 0.0533 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 18.82 | 17.25 | 1324 | 800 | 1.6540 | 1.1903 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 20.79 | 17.25 | 16 | 1001 | 0.0160 | -0.0128 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 20.79 | 17.25 | 1468 | 1001 | 1.4656 | 1.1348 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 20.79 | 17.25 | 13 | 1001 | 0.0130 | -0.0471 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 20.79 | 17.25 | 1484 | 1001 | 1.4816 | 1.1388 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 22.76 | 17.25 | 21 | 1193 | 0.0176 | 0.0327 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 22.76 | 17.25 | 1599 | 1193 | 1.3397 | 1.0980 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 22.76 | 17.25 | 26 | 1193 | 0.0218 | 0.0694 | MN20160310_N02 | E21 |